rxstat › Shortages › Olmesartan Medoxomil

Olmesartan Medoxomil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Olmesartan Medoxomil products are in shortage in Canada (2 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 / 24
In shortage since
May 7, 2024
Reports on file
102
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-OLMESARTAN
40MG · TABLET · APOTEX INC
DIN 02453460 · since Nov 12, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-OLMESARTAN
20MG · TABLET · APOTEX INC
DIN 02453452 · since May 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
GLN-OLMESARTAN
40MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02469820 · ended Jul 3, 2026 · Shortage of an inactive ingredient or component.
Resolved
SANDOZ OLMESARTAN
40MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02443422 · ended May 25, 2026 · Demand increase for the drug.
Resolved
ACH-OLMESARTAN
40MG · TABLET · ACCORD HEALTHCARE INC
DIN 02456338 · ended May 1, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
NRA-OLMESARTAN
20MG · TABLET · NORA PHARMA INC
DIN 02499258 · ended May 1, 2026 · Disruption of the manufacture of the drug.
Resolved
NRA-OLMESARTAN
40MG · TABLET · NORA PHARMA INC
DIN 02499266 · ended May 1, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-OLMESARTAN
40MG · TABLET · PHARMASCIENCE INC
DIN 02461315 · ended Apr 19, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ OLMESARTAN
40MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02443422 · ended Mar 23, 2026 · Disruption of the manufacture of the drug.
Resolved
GLN-OLMESARTAN
40MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02469820 · ended Apr 15, 2026 · Demand increase for the drug.
Resolved
GLN-OLMESARTAN
20MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02469812 · ended Apr 23, 2026 · Demand increase for the drug.
Resolved
SANDOZ OLMESARTAN
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02443414 · ended Apr 6, 2026 · Delay in shipping of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Olmesartan Medoxomil is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Olmesartan Medoxomil is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).

Recent changes

Common questions

When will Olmesartan Medoxomil be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Olmesartan Medoxomil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, plain)

Partial shortageCandesartan Cilexetil20 of 59 reported products affected · est. return Dec 31, 2020Partial shortageIrbesartan10 of 43 reported products affected · est. return Dec 30, 2022Partial shortageLosartan16 of 45 reported products affected · est. return Dec 31, 2026Partial shortageTelmisartan3 of 26 reported products affectedPartial shortageValsartan3 of 43 reported products affected · est. return Jun 19, 2026No current shortageAzilsartan Medoxomil

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.